Skip to content

High-resolution ultrasonography of peripheral nerves in neurofibromatosis

High-resolution ultrasonography of peripheral nerves in neurofibromatosis - HRUS of peripheral nerves in NF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44058
Enrollment
30
Registered
2015-12-03
Start date
2016-01-05
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurofibromatosis von Recklinghausen disease

Interventions

None listed

Sponsors

Sint Elisabeth Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Confirmed neurofibromatosis type 1 or type 2 - Age between 18 years and 80 years

Exclusion criteria

Exclusion criteria: - Physical inability to conduct ultrasound or electrodiagnostics (eg. due to cast, recent operation, reconstructive surgery on extremities)

Design outcomes

Primary

MeasureTime frame
High resolution ultrasonography (HRUS) of the peripheral nerves will be performed according to a HRUS protocol. A 7-18MHz transducer will be used during all examinations. Every nerve will be judged on size, echogenicity and vascularity. Images of the peripheral nerves at anatomical landmarks, or abnormalities will be saved in order to be reviewed at a later stage. Sonography data and abnormalities will be used as primary outcome measure. Follow-up 1 year: Sonography will be performed again after 1 year with use of the same protocol. primary outcome is the development of sonographic abnormalities over time.

Secondary

MeasureTime frame
Interview The interview will be focused on symptoms of the patients (e.g. subcutaneous nodules, numbness, pain and loss of strength). The family history specific to neurofibromatosis shall also be asked. Neurologic examination The neurologic examination will be performed based on the protocol. Also, there will be attention for atrophy, dysfunction of cranial nerves and deep tendon reflexes. Electrodiagnostic tests All patients will be examined according to protocol by electrodiagnostic tests. Sensory and motor conduction speed will be measured. The abovementioned data will be collected in order to determine the possible correlation between those findings and findings in sonography. Follow-up: The relationship between development of sonographic abnormalities and development of clinical symptoms will be used as a secundary outcome.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)